Viemed Healthcare (NASDAQ:VMD) Releases Earnings Results, Misses Expectations By $0.03 EPS

05 May 2026, 22:36 by Teresa Graham · The Cerbat Gem

Viemed Healthcare (NASDAQ:VMD – Get Free Report) posted its earnings results on Tuesday. The company reported $0.06 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.03), FiscalAI reports. The business had revenue of $75.41 million during the quarter, compared to the consensus estimate of $74.40 million. Viemed Healthcare had a return on equity of 10.72% and a net margin of 5.53%.

Viemed Healthcare Stock Up 2.3%

Viemed Healthcare stock traded up $0.22 during trading hours on Tuesday, hitting $9.70. 252,431 shares of the stock traded hands, compared to its average volume of 248,369. The company has a market cap of $373.26 million, a PE ratio of 26.22 and a beta of 1.15. The company has a current ratio of 1.18, a quick ratio of 1.06 and a debt-to-equity ratio of 0.08. The firm’s 50-day moving average price is $9.33 and its two-hundred day moving average price is $7.96. Viemed Healthcare has a one year low of $5.93 and a one year high of $10.18.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on VMD shares. Zacks Research raised Viemed Healthcare to a “hold” rating in a research note on Thursday, January 8th. Wall Street Zen raised Viemed Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Saturday, February 14th. Two equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat, the stock currently has a consensus rating of “Hold”.

Check Out Our Latest Stock Report on Viemed Healthcare

Insiders Place Their Bets

In other Viemed Healthcare news, President Michael Moore sold 65,000 shares of the firm’s stock in a transaction that occurred on Friday, March 20th. The shares were sold at an average price of $8.77, for a total transaction of $570,050.00. Following the completion of the transaction, the president owned 1,585,812 shares of the company’s stock, valued at approximately $13,907,571.24. This trade represents a 3.94% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders sold 136,802 shares of company stock valued at $1,237,976 over the last 90 days. 20.00% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Viemed Healthcare

Several institutional investors and hedge funds have recently made changes to their positions in VMD. Martingale Asset Management L P boosted its holdings in Viemed Healthcare by 6.0% in the fourth quarter. Martingale Asset Management L P now owns 42,483 shares of the company’s stock worth $316,000 after purchasing an additional 2,399 shares during the last quarter. Invesco Ltd. lifted its stake in shares of Viemed Healthcare by 17.1% during the 4th quarter. Invesco Ltd. now owns 21,773 shares of the company’s stock valued at $162,000 after buying an additional 3,173 shares in the last quarter. Barclays PLC lifted its stake in shares of Viemed Healthcare by 2.7% during the 4th quarter. Barclays PLC now owns 131,759 shares of the company’s stock valued at $979,000 after buying an additional 3,480 shares in the last quarter. Rhumbline Advisers lifted its stake in shares of Viemed Healthcare by 9.0% during the 2nd quarter. Rhumbline Advisers now owns 51,456 shares of the company’s stock valued at $356,000 after buying an additional 4,228 shares in the last quarter. Finally, Gabelli Funds LLC lifted its stake in Viemed Healthcare by 4.3% in the 2nd quarter. Gabelli Funds LLC now owns 121,510 shares of the company’s stock worth $840,000 after purchasing an additional 5,000 shares in the last quarter. Institutional investors own 74.24% of the company’s stock.

Viemed Healthcare Company Profile

(Get Free Report)

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.